Your browser doesn't support javascript.
loading
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
Salaj, P; Brabec, P; Penka, M; Pohlreichova, V; Smejkal, P; Cetkovsky, P; Dusek, L; Hedner, U.
Affiliation
  • Salaj P; Institute of Hematology and Blood Transfusion, Prague, Czech Republic. peter.salaj@uhkt.cz
Haemophilia ; 15(3): 752-9, 2009 May.
Article in En | MEDLINE | ID: mdl-19432926
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemostatics / Factor VIIa / Blood Coagulation Factor Inhibitors / Hemarthrosis / Hemophilia A Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemostatics / Factor VIIa / Blood Coagulation Factor Inhibitors / Hemarthrosis / Hemophilia A Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2009 Document type: Article Affiliation country: Country of publication: